NYU Langone Health and Dana-Farber Cancer Institute built an oncology decision support platform to guide clinicians through treatment decisions. Now, the institutions are commercializing the product so other health systems can use it too.
Novel Molecular Glue Discovery Platform Unlocks Undruggable Cancer Targets
Targeted protein degradation is a therapeutic strategy that leverages the ubiquitin–proteasome system to eliminate disease-associated proteins—including those that have traditionally been considered undruggable. Protein degraders
